Company Overview and News

0
Linde sells assets for $3.3 billion to help get Praxair deal cleared

2018-07-16 reuters
FRANKFURT (Reuters) - Linde (LING.DE) is raising $3.3 billion from selling North and South American assets to a consortium of German gases firm Messer and buyout group CVC as it seeks clearance for a planned $87 billion merger with U.S. group Praxair (PX.N).
4091 AI

0
EU regulators to okay US$83 billion Linde, Praxair deal: Sources

2018-07-13 channelnewsasia
BRUSSELS: EU antitrust regulators are set to approve gases groups Linde and Praxair's US$83 billion merger after pledging to sell Praxair's assets to boost a Japanese rival in Europe, two people familiar with the matter said on Thursday.
4091 AI

0
Exclusive: EU regulators to okay US$83 billion Linde, Praxair deal - sources

2018-07-12 channelnewsasia
EU antitrust regulators are set to approve gases groups Linde and Praxair's US$83 billion merger after pledging to sell Praxair's assets to boost a Japanese rival in Europe, two people familiar with the matter said on Thursday.
4091 AI

0
Exclusive: EU regulators to okay $83 billion Linde, Praxair deal - sources

2018-07-12 reuters
BRUSSELS (Reuters) - EU antitrust regulators are set to approve gases groups Linde (LING.DE) and Praxair’s (PX.N) $83 billion merger after pledging to sell Praxair’s assets to boost a Japanese rival in Europe, two people familiar with the matter said on Thursday.
4091 AI

110
Fuel Cells, No Longer Too Early

2018-07-03 seekingalpha
Occasionally, I find myself accepting that an “out there” investment idea is worth a leap-of-faith – hydrogen fuel cells.
NTLA RDS.B RDS.A TM MS.PRE CRSP MS.PRF MS.PRG RDSB UTX RDSA MS.PRA HMC ABB EDIT MS.PRI MS.PRK RYDBF MS RYDAF AI BLDP

1
Sweltering Europe loses its fizz as C02 shortage hits drinkers

2018-06-28 lifestyle.inquirer.net
It’s peak season for bars and barbecues in Europe as a summer heatwave coincides with the World Cup on TV.
AI

1
Sweltering Europe loses its fizz as Co2 shortage hits drinkers

2018-06-27 yahoo
London (AFP) - It's peak season for bars and barbecues in Europe as a summer heatwave coincides with the World Cup on TV. So probably not the best time for drinks companies to be running out of the gas that puts the fizz into beer and sodas.
AI

15
Looming beer shortage could leave World Cup fans gasping

2018-06-27 theage.com.au
A shortage of carbon dioxide has hit some of Europe's biggest brewers and soft drink makers, disrupting production just as drinkers' thirst peaks due to a heatwave and the World Cup soccer tournament, in which England is doing exceptionally well.
BUD AHBIF AI

15
Looming beer shortage could leave World Cup fans gasping

2018-06-27 smh.com.au
A shortage of carbon dioxide has hit some of Europe's biggest brewers and soft drink makers, disrupting production just as drinkers' thirst peaks due to a heatwave and the World Cup soccer tournament, in which England is doing exceptionally well.
BUD AHBIF AI

15
Looming beer shortage risks leaving England's World Cup fans gasping

2018-06-27 reuters
LONDON (Reuters) - A shortage of carbon dioxide has hit Britain’s biggest brewers and soft drink makers, disrupting production just as drinkers’ thirst peaks due to a heatwave and a World Cup soccer tournament in which England is doing unusually well.
BUD AHBIF AI

13
Exclusive: Taiyo Nippon, Carlyle frontrunners to buy Linde and Praxair assets - sources

2018-06-20 channelnewsasia
Taiyo Nippon Sanso Corp and private equity firm Carlyle Group have emerged as frontrunners to buy assets that gases groups Linde and Praxair need to divest to seal their planned merger, people close to the matter said.
4091 CG AI

100
Stop Buying Commodities Funds

2018-06-19 seekingalpha
We’ve never been fans of direct commodities investments and have been warning about the lack of risk adjusted returns that commodities funds offer investors for years. In previous articles, we focused on the structural issues with commodities markets and commodities funds that make them unworthy of inclusion in investors’ portfolios. In this article, we want to focus on a different aspect of commodities funds that make them unattractive.
HAL RIO RIO BLT XOM APD PSX COP SHW RTPPF RTNTF VDE BHPBF VLO DWDP VALE PPG PX BHP RIO CVX DBC VAW BBL BHP PDBC SLB BHPLF AI

18
Plug Power to Participate in 2018 National Fuel Cell & Hydrogen Forum

2018-06-12 globenewswire
CEO Andy Marsh to Speak; Will be Named Chairman of the Fuel Cell and Hydrogen Energy Association
PLUG AI

53
CORRECTED-Linde-Praxair asset sale narrows to strategic bidders -sources

2018-06-08 reuters
FRANKFURT/LONDON/NEW YORK (Reuters) - Industrial gas companies Linde AG (LING.DE) and Praxair Inc (PX.N) have slashed the bidding pool for the more than $4 billion worth of assets they are jointly selling in a move that will favor Japan’s Taiyo Nippon Sanso Corp (4091.T), people familiar with the matter said on Friday.
4091 BGX PX CG BGLF BX AI BGB

53
Linde-Praxair merger narrows in favor of strategic bidders -sources

2018-06-08 reuters
FRANKFURT/LONDON/NEW YORK June 8 (Reuters) - Industrial gas companies Linde AG and Praxair Inc have slashed the bidding pool for the more than $4 billion worth of assets they are jointly selling in a move that will favor Japan’s Taiyo Nippon Sanso Corp, people familiar with the matter said on Friday.
4091 BGX PX CG BGLF BX AI BGB

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:AI / AIR LIQUIDE on message board site Silicon Investor.

Blockchain Mainstream Politics and Economics
American Airlines Group, Inc. Baidu (BIDU)
Rocky Mountain High Brands wagerr - betting belongs on the blockchain
NPT.C - Plaintree Systems Inc. Aircraft leasing companies. FLY, AER, WLFC
Did the Great Experiment Fail? Lions Gate Entertainment Corporation